RO4929097 in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma That Can Be Removed by Surgery

NCT01216787 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

NIH

Sponsor class

Stopped Study drug not available.

Conditions

Stage IIIB Melanoma
Stage IIIC Melanoma
Stage IV Melanoma

Interventions

DRUG: gamma-secretase/Notch signalling pathway inhibitor RO4929097
OTHER: pharmacological study
PROCEDURE: therapeutic conventional surgery
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)